Epidemiology of Lung Cancer in Women: A Hospital-Based Descriptive Study
Received Date : 08 Jan 2020
Accepted Date : 18 Mar 2020
Available Online : 17 Apr 2020
Doi: 10.37047/jos.2020-73409 - Article's Language: EN
J Oncol Sci.2020;6(1):29-34
This is an open access article under the CC BY-NC-ND license
Objective: Lung cancer required much greater attention as it is the most common cause of death. According to statistics in 2010, 85% of lung cancer in men and 57% in women are attributed to tobacco smoking. The aim of the study was to describe the clinical and pathologic characteristics of the female patients who visited the Department of Medical Oncology of Acıbadem Maslak Hospital between 2009 and 2017. Material and Methods: Clinicopathologic data collected for analyses included age at diagnosis, history of cigarette use, comorbid conditions, family history, tumor-node-metastasis stage, pathologic subtypes of lung carcinoma, and the given therapy. From July 2017 to February 2018, we collected data of 540 female patients with lung cancer at the Department of Medical Oncology of Acıbadem Maslak Hospital. Results: Among 540 patients, 185 patients (34.3%) were nonsmokers, 106 (19.6%) were current smokers, and 210 (38.9%) were former smokers. Data on common comorbid conditions such as hypertension, diabetes mellitus, and coronary artery disease were collected, and the conditions were classified according to the smoking status of the patients. Among current and former smokers, 36.7% were diagnosed with hypertension, 18.3% with diabetes mellitus, and 11% with coronary artery diseases. Moreover, 75% of all patients were diagnosed with nonsmall-cell lung cancer (NSCLC), whereas 16% were diagnosed with small-cell lung cancer. Adenocarcinoma is the most common histological type of cancer seen in patients with NSCLC (77%), followed by patients with squamous cell carcinoma (15%). Conclusion: Factors other than tobacco use, such as radon exposure, air pollution, radiation exposure, and an unbalanced diet are responsible for the increasing incidence of lung cancer. However, further studies are warranted to investigate the cause of the epidemic differences in women, particularly the gender bias in nonsmoker patients with lung cancer.
  1. International Agency for Research on Cancer. World Health Organization (WHO). Global Cancer Observatory; 2018. (cited 2019, July 8).
  2. Chakraborty S, Ganti AK, Marr A, Batra SK. Lung cancer in women: role of estrogens. Expert Rev Respir Med J. 2010;4(4):509-518. [Crossref]  [PubMed]  [PMC] 
  3. -db/istatistik/2014-RAPOR._uzuuun.pdf
  4. Pigeot I, De Henauw S, Foraita R, Jahn I, Ahrens W. Primary prevention from the epidemiology perspective: three examples from the practice. BMC Med Res Methodol. Feb 2010;(10):10. [Crossref]  [PubMed]  [PMC] 
  5. Antony GK, Bertino E, Franklin M, Otterson GA, Dudek AZ. Small cell lung cancer in never smokers: report of two cases. J Thorac Oncol. 2010;5(5):747-748. [Crossref]  [PubMed] 
  6. Roh MS. Molecular pathology of lung cancer: current status and future directions. Tuberc Respir Dis (Seoul). 2014;77(2):49-54 [Crossref]  [PubMed]  [PMC] 
  7. Jemal A, Miller KD, Ma J, et al. Higher lung cancer incidence in young women than young men in the United States. N Engl J Med. 2018;378(21):1999-2009. [Crossref]  [PubMed] 
  8. Samet JM, Avila-Tang E, Boffetta P, et al. Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin Cancer Res. 2009;15(18):5626-5645. [Crossref]  [PubMed]  [PMC] 
  9. Xue Y, Jiang Y, Jin S, Li Y. Association between cooking oil fume exposure and lung cancer among Chinese nonsmoking women: a meta-analysis. Onco Targets Ther. May 2016;(9):2987-2992. [Crossref]  [PubMed]  [PMC] 
  10. Dutkowska AE, Antczak A. Comorbidities in lung cancer. Pneumonol Alergol Pol. 2016;84(3):186-192. [Crossref]  [PubMed] 
  11. Mao Y, Yang D, He J, Krasna MJ. Epidemiology of lung cancer. Surg Oncol Clin N Am. 2016;25(3):439-445. [Crossref]  [PubMed]